Schedule 13D ownership disclosure

Eton Pharmaceuticals, Inc.

Security class unavailable

Event date: 2024-04-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-24-017144
Form type
SC 13D/A
Filer
Eton Pharmaceuticals, Inc.
CIK
CIK 1710340
Filed
Apr 30, 2024
Reporting period
Apr 26, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub